UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 431

Sortiert nach

Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

Clinical infectious diseases, 2010-11, Vol.51 (10), p.1127-1137

2010

Volltextzugriff (PDF)

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

The Journal of infection, 2015-07, Vol.71 (1), p.43-52

2015

Volltextzugriff (PDF)

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months

Canadian Medical Association journal (CMAJ), 2015-04, Vol.187 (7), p.E215

2015

Volltextzugriff (PDF)

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life: A Randomized Comparative Trial

The Pediatric infectious disease journal, 2010-11, Vol.29 (11), p.e71-e79

2010

Volltextzugriff (PDF)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

Canadian Medical Association journal (CMAJ), 2013-10, Vol.185 (15), p.E715

2013

Volltextzugriff (PDF)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2008-01, Vol.299 (2), p.173

2008

Volltextzugriff (PDF)

Persistence of Bactericidal Antibodies to 5 Years of Age After Immunization With Serogroup B Meningococcal Vaccines at 6, 8, 12 and 40 Months of Age

The Pediatric infectious disease journal, 2014-07, Vol.33 (7), p.760-766

2014

Volltextzugriff (PDF)

Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses: A Follow-on Study to a Randomized Clinical Trial

The Pediatric infectious disease journal, 2013-10, Vol.32 (10), p.1116-1121

2013

Volltextzugriff (PDF)

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

The Pediatric infectious disease journal, 2010-12, Vol.29 (12), p.e80-e90

2010

Volltextzugriff (PDF)

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody

The Journal of immunology (1950), 2012-09, Vol.189 (5), p.2673-2681

2012

Volltextzugriff (PDF)

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

The Pediatric infectious disease journal, 2009-03, Vol.28 (3), p.186-193

2009

Volltextzugriff (PDF)

Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-up Study

The Pediatric infectious disease journal, 2012-10, Vol.31 (10), p.1069-1073

2012

Volltextzugriff (PDF)

Genetic material should be routinely collected in clinical vaccine trials – High consent rates can be achieved across all age groups

Vaccine, 2013-06, Vol.31 (25), p.2744-2748

2013

Volltextzugriff (PDF)

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

The Pediatric infectious disease journal, 2011-11, Vol.30 (11), p.e203-e208

2011

Volltextzugriff (PDF)

Evaluation of Haemophilus influenzae Type b Vaccine for Routine Immunization in Nepali Infants

The Pediatric infectious disease journal, 2012-04, Vol.31 (4), p.e66-e72

2012

Volltextzugriff (PDF)

MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1

eLife, 2021-01, Vol.10

2021

Volltextzugriff (PDF)

Commentary: Challenging the assumptions of body mass index and mortality in use of extracorporeal membrane oxygenation for adult respiratory distress syndrome

The Journal of thoracic and cardiovascular surgery, 2024-02

2024

Volltextzugriff (PDF)

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

Nature genetics, 2019-10, Vol.51 (10), p.1450-1458

2019

Volltextzugriff (PDF)

Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study

European journal of nuclear medicine and molecular imaging, 2022-05, Vol.49 (6), p.2023-2036

2022

Volltextzugriff (PDF)

Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries

The Lancet global health, 2017-09, Vol.5 (9), p.e875-e887

2017

Volltextzugriff (PDF)

Massive Activation of Archaeal Defense Genes during Viral Infection

Journal of Virology, 2013-08, Vol.87 (15), p.8419-8428

2013

Volltextzugriff (PDF)

Adult Outcomes in Autism: Community Inclusion and Living Skills

Journal of autism and developmental disorders, 2014-12, Vol.44 (12), p.3006-3015

2014

Volltextzugriff (PDF)

Visual hallucinations induced by Ganzflicker and Ganzfeld differ in frequency, complexity, and content

Scientific reports, 2024-01, Vol.14 (1), p.2353-2353, Article 2353

2024

Volltextzugriff (PDF)

Artificial Intelligence System Approaching Neuroradiologist-level Differential Diagnosis Accuracy at Brain MRI

Radiology, 2020-06, Vol.295 (3), p.626-637

2020

Volltextzugriff (PDF)

1 – 25 von 431

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(397)
Mit Volltextzugriff
(345)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Multicenter, Open-Label, Randomized Phase II Controlled Trial of an Investigational Recombinant Meningococcal Serogroup B Vaccine With and Without Outer Membrane Vesicles, Administered in Infancy

Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months

Immunogenicity of Two Investigational Serogroup B Meningococcal Vaccines in the First Year of Life: A Randomized Comparative Trial

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial

Persistence of Bactericidal Antibodies to 5 Years of Age After Immunization With Serogroup B Meningococcal Vaccines at 6, 8, 12 and 40 Months of Age

Bactericidal Antibody Persistence 2 Years After Immunization With 2 Investigational Serogroup B Meningococcal Vaccines at 6, 8 and 12 Months and Immunogenicity of Preschool Booster Doses: A Follow-on Study to a Randomized Clinical Trial

Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody

Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants

H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

Persistence of Antibody Response Following a Booster Dose of Hib-MenC-TT Glycoconjugate Vaccine to Five Years: A Follow-up Study

Genetic material should be routinely collected in clinical vaccine trials – High consent rates can be achieved across all age groups

Persistence of Serum Bactericidal Antibody One Year After a Booster Dose of Either a Glycoconjugate or a Plain Polysaccharide Vaccine Against Serogroup C Neisseria meningitidis Given to Adolescents Previously Immunized With a Glycoconjugate Vaccine

Evaluation of Haemophilus influenzae Type b Vaccine for Routine Immunization in Nepali Infants

MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1

Commentary: Challenging the assumptions of body mass index and mortality in use of extracorporeal membrane oxygenation for adult respiratory distress syndrome

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study

Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countries

Massive Activation of Archaeal Defense Genes during Viral Infection

Adult Outcomes in Autism: Community Inclusion and Living Skills

Visual hallucinations induced by Ganzflicker and Ganzfeld differ in frequency, complexity, and content

Artificial Intelligence System Approaching Neuroradiologist-level Differential Diagnosis Accuracy at Brain MRI

Suchergebnisse filtern